Literature DB >> 16912219

A critical role for the short intracellular C terminus in receptor activity-modifying protein function.

Madhara Udawela1, George Christopoulos, Maria Morfis, Arthur Christopoulos, Siying Ye, Nanda Tilakaratne, Patrick M Sexton.   

Abstract

Receptor activity-modifying proteins (RAMPs) interact with and modify the behavior of the calcitonin receptor (CTR) and calcitonin receptor-like receptor (CLR). We have examined the contribution of the short intracellular C terminus, using constructs that delete the last eight amino acids of each RAMP. C-Terminal deletion of individual RAMPs had little effect on the signaling profile induced when complexed with CLR in COS-7 or human embryonic kidney (HEK)293 cells. Likewise, confocal microscopy revealed each of the mutant RAMPs translocated hemagglutinin-tagged CLR to the cell surface. In contrast, a pronounced effect of RAMP C-terminal truncation was seen for RAMP/CTRa complexes, studied in COS-7 cells, with significant attenuation of amylin receptor phenotype induction that was stronger for RAMP1 and -2 than RAMP3. The loss of amylin binding upon C-terminal deletion could be partially recovered with overexpression of Galpha(s), suggesting an impact of the RAMP C terminus on coupling of G proteins to the receptor complex. In HEK293 cells the c-Myc-RAMP1 C-terminal deletion mutant showed high receptor-independent cell surface expression; however, this construct showed low cell surface expression when expressed alone in COS-7 cells, indicating interaction of RAMPs with other cellular components via the C terminus. This mutant also had reduced cell surface expression when coexpressed with CTR. Thus, this study reveals important functionality of the RAMP C-terminal domain and identifies key differences in the role of the RAMP C terminus for CTR versus CLR-based receptors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16912219     DOI: 10.1124/mol.106.024257

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  14 in total

Review 1.  Structure-function relationships of the N-terminus of receptor activity-modifying proteins.

Authors:  Tao Qi; Debbie L Hay
Journal:  Br J Pharmacol       Date:  2009-12-10       Impact factor: 8.739

Review 2.  Receptor Activity-Modifying Proteins (RAMPs): New Insights and Roles.

Authors:  Debbie L Hay; Augen A Pioszak
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-10-23       Impact factor: 13.820

3.  Molecular basis of association of receptor activity-modifying protein 3 with the family B G protein-coupled secretin receptor.

Authors:  Kaleeckal G Harikumar; John Simms; George Christopoulos; Patrick M Sexton; Laurence J Miller
Journal:  Biochemistry       Date:  2009-12-15       Impact factor: 3.162

Review 4.  Amylin structure-function relationships and receptor pharmacology: implications for amylin mimetic drug development.

Authors:  Rebekah L Bower; Debbie L Hay
Journal:  Br J Pharmacol       Date:  2016-05-18       Impact factor: 8.739

Review 5.  Dawn of a New RAMPage.

Authors:  D Stephen Serafin; Natalie R Harris; Natalie R Nielsen; Duncan I Mackie; Kathleen M Caron
Journal:  Trends Pharmacol Sci       Date:  2020-02-27       Impact factor: 14.819

6.  Receptor activity modifying proteins (RAMPs) interact with the VPAC2 receptor and CRF1 receptors and modulate their function.

Authors:  D Wootten; H Lindmark; M Kadmiel; H Willcockson; K M Caron; J Barwell; T Drmota; D R Poyner
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

Review 7.  RAMPs as allosteric modulators of the calcitonin and calcitonin-like class B G protein-coupled receptors.

Authors:  Augen A Pioszak; Debbie L Hay
Journal:  Adv Pharmacol       Date:  2020-01-27

Review 8.  Structure and function of the melanocortin2 receptor accessory protein (MRAP).

Authors:  Patricia M Hinkle; Julien A Sebag
Journal:  Mol Cell Endocrinol       Date:  2008-11-06       Impact factor: 4.102

9.  Dissection of functional residues in receptor activity-modifying proteins through phylogenetic and statistical analyses.

Authors:  Alfonso Benítez-Páez; Sonia Cárdenas-Brito
Journal:  Evol Bioinform Online       Date:  2008-04-28       Impact factor: 1.625

10.  Pharmacological characterisation of mouse calcitonin and calcitonin receptor-like receptors reveals differences compared with human receptors.

Authors:  Michael L Garelja; Rebekah L Bower; Margaret A Brimble; Shanan Chand; Paul W R Harris; Muhammad Aqfan Jamaluddin; Jakeb Petersen; Andrew Siow; Christopher S Walker; Debbie L Hay
Journal:  Br J Pharmacol       Date:  2021-10-15       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.